Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2002

View Archived Issues

Possible mechanism by which vitamin E reduces the risk of prostate cancer

CYP1B1 converts resveratrol to the antileukemic agent piceatannol

Important new drug for acute lung injury launched for the first time in Japan

Novel long-acting GLP-1 analogue characterized at ADA meeting

Selective H3 receptor antagonist from Abbott effective in animal model of diet-induced obesity

Preclinical and clinical data for DPP-IV inhibitor P-32/98 discussed at ADA meeting

Microbially produced alpha-glucosidase inhibitor with promising preclinical profile

PhotoCure subscribes for shares in Anticancer Therapeutic Inventions

Both type 1 and 2 diabetics may benefit from Exubera according to phase III data

Bioenvision initiates clofarabine clinical program

First phase II/III results for Neurodex in ALS patients with emotional lability

ZT-1 tested in first-in-man trials

Ethypharm and Viatris collaborate on Flashtab formulation of tramadol

Rifalazil heads ActivBiotics' pipeline

Scientists at K.U. Leuven present novel contrast agents

Preparation and use of beta3-adrenoceptor agonists described in Lilly patent

New STAT6 inhibitors in early development at Tularik

GABA-A ligands and their use in anxiety and convulsions

Use of the Aerodose inhaler in type 2 diabetic patients

Transdermal administration of basal insulin through micropores for type 2 diabetes

AstraZeneca claims P2T antagonists for antiplatelet therapy

BioCryst describes PNP inhibitors with potential in cancer therapy

Novel antitumor naphthyridines identified by Dainippon

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...